drugset / Trial / NCT00654992
Effect of Erythropoietin (EPO) in Kidney After Cardiac Surgery
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to determine whether erythropoietin is effective in preventing acute kidney dysfunction after coronary artery bypass grafting surgery.
Timeline
- Start
- 2006-09
- Primary completion
- 2008-02
- Completion
- 2009-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Erythropoietin Beta | Protein / enzyme biologic | 300 iu/kg | — |